GlassScriptPhysician profile
Mary Ann Bender
NPI 1184795239
$2,547.56
in general payments reported to CMS, 2019-2025
26 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.39 · 2020: $148 · 2021: $467 · 2022: $381 · 2023: $693 · 2024: $328 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $620.04 | 2019-2025 | Grafix, Collagenase Santyl, Stravix Pl |
| Orthofix Medical, INC. | $243.05 | 2020-2025 | Physio-Stim |
| Organogenesis INC. | $187.66 | 2022-2023 | Puraply |
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Zimmer Biomet Holdings, INC. | $157.76 | 2019-2021 | |
| Nevro Corp. | $136.92 | 2022-2023 | Senza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $131.95 | 2022-2025 | Jublia |
| Pacira Pharmaceuticals Incorporated | $123.63 | 2025 | Exparel |
| Melinta Therapeutics, LLC | $111.16 | 2020-2024 | Kimyrsa, Orbactiv |
| Abbott Laboratories | $103.32 | 2023 | Proclaim, Hi-Torque Command |
| Paratek Pharmaceuticals, INC. | $94.42 | 2020-2025 | Nuzyra |
| Bioventus LLC | $51.66 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $48.41 | 2025 | |
| Acumed LLC | $47.43 | 2023 | Acumed, Osteomed |
| Integra Lifesciences Corporation | $41.49 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $37.95 | 2021-2023 | |
| Horizon Therapeutics Plc | $37.55 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $30.02 | 2023 | |
| Urgo Medical North America, LLC | $29.18 | 2025 | Urgok2 |
| Globus Medical, INC. | $27.58 | 2025 | Senza |
| Acera Surgical, INC. | $26.96 | 2022 | |
| Depuy Synthes Sales INC. | $20.04 | 2025 | Va-Lcp |
| Paragon 28, INC. | $18.54 | 2025 | Phantom Fibula Nail |
| Cpm Medical Consultants, LLC | $16.15 | 2023 | Orbitum Staple System |
| Hikma Pharmaceuticals USA | $14.46 | 2021 | |
| Next Science LLC | $12.98 | 2023 | Xperience, Surgx, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ann Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.